ds-5 analyzer (Drew Scientific)
90
Structured Review
Drew Scientific
ds-5 analyzer
Ds 5 Analyzer, supplied by Drew Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ds-5+analyzer/ds+5+analyzer/pm39700591-71-9-11
Average 90 stars, based on 1 article reviews
Ds 5 Analyzer, supplied by Drew Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ds-5+analyzer/ds+5+analyzer/pm39700591-71-9-11
Average 90 stars, based on 1 article reviews
ds-5 analyzer - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Linagliptin plus insulin for hyperglycemia immediately after renal transplantation: A comparative study. Article Snippet: Aims: Post-renal-transplanted patients frequently present hyperglycemia immediately after the procedure.. The goal of this work was to evaluate the effect of linagliptin + insulin in post-renal-transplanted patients with hyperglycemia.. Methods: Retrospective comparative study in post-renal transplanted patients with hyperglycemia after transplantation who were treated with linagliptin 5 mg daily plus insulin vs insulin alone for 5 days after renal transplantation with hyperglycemia. Article Title: Effect of metformin and metformin/linagliptin on gut microbiota in patients with prediabetes. Article Snippet: HbA1c was determined using highperformance liquid chromatography with Article Title: Comparison between metabolically healthy obesity and metabolically unhealthy obesity by different definitions among Mexican children. Article Snippet: Background: There is no consensus on the definition of metabolically healthy obesity (MHO) and the diagnostic criteria in children.. Objectives: To estimate the prevalence of MHO and compare clinical and biochemical characteristics between MHO and metabolically unhealthy obesity (MUO), and to evaluate the association between MUO and cardiovascular disease (CVD) risk, anthropometrics and family background using different definitions in children.. Methods: This was a cross-sectional study. Article Title: The effect of semaglutide combined with metformin on liver inflammation and pancreatic beta-cell function in patients with type 2 diabetes and non-alcoholic fatty liver disease. Article Snippet: Background: Type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD) were often coexistent conditions driven by insulin resistance and systemic inflammation.. Effective management strategies that address both metabolic disorders were urgently needed.. This study investigates the effect of combining semaglutide, a glucagon-like peptide-1 receptor agonist, with metformin on liver inflammation and pancreatic beta-cell function in patients with T2DM and NAFLD. Article Title: Clinical and Metabolic Characteristics among Mexican Children with Different Types of Diabetes Mellitus Article Snippet: [ ] HbA1C was determined using high-performance liquid chromatography with a Article Title: Effect of linagliptin on glucose metabolism and pancreatic beta cell function in patients with persistent prediabetes after metformin and lifestyle Article Snippet: HbA1c was determined using high-performance liquid chromatography with a Article Title: Effect of linagliptin plus insulin in comparison to insulin alone on metabolic control and prognosis in hospitalized patients with SARS-CoV-2 infection Article Snippet: Glycated hemoglobin A 1C (HbA 1C ) values were determined using high-performance liquid chromatography with a |